Terumo (OTCMKTS:TRUMY) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Terumo (OTCMKTS:TRUMYGet Free Report) released its earnings results on Friday. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.03), Zacks reports. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.84 billion. Terumo had a return on equity of 9.01% and a net margin of 11.74%.

Terumo Stock Performance

Shares of TRUMY stock opened at $12.68 on Friday. The stock has a market cap of $18.70 billion, a PE ratio of 21.86 and a beta of 0.62. The company has a quick ratio of 0.89, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. Terumo has a 52-week low of $12.08 and a 52-week high of $19.64. The business has a 50-day simple moving average of $13.08 and a 200-day simple moving average of $14.00.

Analyst Ratings Changes

A number of research firms have issued reports on TRUMY. Nomura raised shares of Terumo to a “hold” rating in a research report on Tuesday, February 24th. Zacks Research raised shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

Check Out Our Latest Stock Report on TRUMY

About Terumo

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

Read More

Earnings History for Terumo (OTCMKTS:TRUMY)

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.